Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

Avantor, Inc. (AVTR) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Avantor, Inc. (AVTR) trades at a P/E ratio of 30.3×. Over the past ten years it has ranged from 0.0× (September 2026) to 341× (January 2021); the current reading is higher than 50% of that period. That is in line with the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 20.1× (57.66%)
FY2023 47.4× 130.60%
FY2022 20.6× (58.05%)
FY2021 49.0× (84.33%)
FY2020 313× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 30.1× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
29 more quarters

Against its own ten years

Low 0.0× High 341×
Ten-year median 30.0×
Current reading's percentile 31

P/E ratio against peers

Company P/E ratio
RGEN Repligen Corporation compare n/m
BAX Baxter International Inc. compare n/m
BLCO Bausch + Lomb Corporation compare n/m
TFX Teleflex Incorporated compare n/m
COO The Cooper Companies, Inc. compare 21.7×
ALGN Align Technology, Inc. compare 23.1×
AVTR Avantor, Inc. 30.3×
ATR AptarGroup, Inc. compare 34.6×
SOLV Solventum Corporation compare 97.3×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AVTR